| Calculation of Filing Fee Tables | |||
| S-1 | |||
| AEON Biopharma, Inc. | |||
| Table 1: Newly Registered and Carry Forward Securities | ☐Not Applicable |
|---|
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Newly Registered Securities | |||||||||||||
| Fees to be Paid | 1 | Equity | Class A Common Stock, par value $0.0001 per share | 457(o) | $ 14,375,000.00 | 0.0001381 | $ 1,985.19 | ||||||
| Fees to be Paid | 2 | Equity | Pre-Funded Warrants | Other | 0.0001381 | $ 0.00 | |||||||
| Fees to be Paid | 3 | Equity | Class A Common Stock underlying Pre-Funded Warrants | Other | 0.0001381 | $ 0.00 | |||||||
| Fees to be Paid | 4 | Equity | Two-Year Milestone Warrants | Other | 0.0001381 | $ 0.00 | |||||||
| Fees to be Paid | 5 | Equity | Class A Common Stock, par value $0.0001 per share, underlying Two-Year Milestone Warrants | 457(o) | $ 14,375,000.00 | 0.0001381 | $ 1,985.19 | ||||||
| Fees to be Paid | 6 | Equity | Five-Year Milestone Warrants | Other | 0.0001381 | $ 0.00 | |||||||
| Fees to be Paid | 7 | Equity | Class A Common Stock, par value $0.0001 per share, underlying Five-Year Milestone Warrants | 457(o) | $ 14,375,000.00 | 0.0001381 | $ 1,985.19 | ||||||
| Fees Previously Paid | |||||||||||||
| Carry Forward Securities | |||||||||||||
| Carry Forward Securities | |||||||||||||
| Total Offering Amounts: | $ 43,125,000.00 | $ 5,955.57 | |||||||||||
| Total Fees Previously Paid: | $ 0.00 | ||||||||||||
| Total Fee Offsets: | $ 0.00 | ||||||||||||
| Net Fee Due: | $ 5,955.57 | ||||||||||||
| Offering Note |
| 1 | Note 1a: In accordance with Rule 416(a), the Registrant is also registering an indeterminate number of additional shares of Common Stock that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions. Note 1b: The Proposed Maximum Aggregate Offering Price of the Common Stock offered hereby (including the shoe) is based on an assumed public offering price of $0.7151 per share, which is equal to the closing price per share of the Registrant's Common Stock on the NYSE American on July 2, 2026. Includes shares of Common Stock issuable upon the Representative's exercise in full of the over-allotment option. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o). | ||||||
| | |||||||
| 2 | See Offering Note 1a. The Proposed Maximum Aggregate Offering Price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants offered and sold in the offering. Accordingly, no separate registration fee is payable with respect to the Pre-Funded Warrants (or the shares of Common Stock issuable upon exercise thereof) pursuant to Rule 457(g). | ||||||
| | |||||||
| 3 | See Offering Note 2. | ||||||
| | |||||||
| 4 | See Offering Note 1a. No separate registration fee is payable with respect to the Two-Year Milestone Warrants or the Five-Year Milestone Warrants (or the Pre-Funded Warrants issuable upon exercise thereof) pursuant to Rule 457(g). The Proposed Maximum Aggregate Offering Price of the Common Stock underlying the Milestone Warrants is calculated based on the assumed exercise price of $0.7151 per share of Common Stock. Includes shares of Common Stock issuable upon the Representative's exercise in full of the over-allotment option. | ||||||
| | |||||||
| 5 | See Offering Note 4. | ||||||
| | |||||||
| 6 | See Offering Note 4. | ||||||
| | |||||||
| 7 | See Offering Note 4. | ||||||
| | |||||||
| Table 2: Fee Offset Claims and Sources | ☑Not Applicable |
|---|
| Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rules 457(b) and 0-11(a)(2) | |||||||||||||
| Fee Offset Claims | |||||||||||||
| Fee Offset Sources | |||||||||||||
| Rule 457(p) | |||||||||||||
| Fee Offset Claims | |||||||||||||
| Fee Offset Sources | |||||||||||||
| Table 3: Combined Prospectuses | ☑Not Applicable |
|---|
| Security Type | Security Class Title | Amount of Securities Previously Registered | Maximum Aggregate Offering Price of Securities Previously Registered | Form Type | File Number | Initial Effective Date | |
|---|---|---|---|---|---|---|---|